Scarica l'app Stockscreener
28.56
3.82%
1.05
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BAX Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$27.51
Aprire:
$28.59
Volume 24 ore:
3.37M
Relative Volume:
0.84
Capitalizzazione di mercato:
$14.66B
Reddito:
$11.89B
Utile/perdita netta:
$-560.00M
Rapporto P/E:
-25.96
EPS:
-1.1
Flusso di cassa netto:
$191.00M
1 W Prestazione:
+0.67%
1M Prestazione:
-4.77%
6M Prestazione:
-11.99%
1 anno Prestazione:
-19.02%
Intervallo 1D:
$28.44
$28.71
Intervallo di 1 settimana:
$27.36
$28.71
Portata 52W:
$26.25
$40.49
Baxter International Inc Stock (BAX) Company Profile
Nome
Baxter International Inc
Settore
Industria
Telefono
(224) 948-2000
Indirizzo
ONE BAXTER PARKWAY, DEERFIELD, IL
Confronta BAX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BAX
Baxter International Inc
|
28.56 | 14.12B | 11.89B | -560.00M | 191.00M | -1.10 |
|
ISRG
Intuitive Surgical Inc
|
501.95 | 183.15B | 9.15B | 2.61B | 1.75B | 7.17 |
|
BDX
Becton Dickinson Co
|
182.58 | 51.96B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
92.22 | 43.85B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
273.37 | 39.21B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
227.31 | 15.73B | 2.90B | 467.20M | 306.90M | 6.37 |
Baxter International Inc Stock (BAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-26 | Ripresa | Goldman | Buy |
| 2025-02-24 | Aggiornamento | Argus | Hold → Buy |
| 2025-02-20 | Ripresa | Barclays | Overweight |
| 2024-07-15 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-05-10 | Downgrade | TD Cowen | Buy → Hold |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-29 | Iniziato | UBS | Neutral |
| 2023-01-06 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-01-05 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2023-01-03 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-12-19 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-12-15 | Downgrade | Deutsche Bank | Buy → Hold |
| 2022-12-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-06-24 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2022-02-18 | Reiterato | KeyBanc Capital Markets | Overweight |
| 2022-02-18 | Reiterato | Morgan Stanley | Overweight |
| 2022-02-18 | Reiterato | Raymond James | Outperform |
| 2022-02-18 | Reiterato | Stifel | Buy |
| 2022-02-18 | Reiterato | UBS | Neutral |
| 2022-02-18 | Reiterato | Wells Fargo | Overweight |
| 2022-02-11 | Iniziato | Goldman | Neutral |
| 2022-01-07 | Ripresa | Citigroup | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-09-13 | Aggiornamento | Cowen | Market Perform → Outperform |
| 2021-09-03 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-05-25 | Iniziato | Barclays | Equal Weight |
| 2021-01-29 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2021-01-06 | Downgrade | UBS | Buy → Neutral |
| 2020-12-15 | Downgrade | Goldman | Buy → Neutral |
| 2020-10-01 | Aggiornamento | Citigroup | Neutral → Buy |
| 2020-09-04 | Downgrade | Argus | Buy → Hold |
| 2020-06-24 | Iniziato | Oppenheimer | Outperform |
| 2020-03-19 | Aggiornamento | Stifel | Hold → Buy |
| 2020-03-18 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2020-03-05 | Iniziato | Citigroup | Neutral |
| 2020-02-13 | Iniziato | Goldman | Buy |
| 2020-01-02 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2019-12-17 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2019-06-26 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-04-08 | Downgrade | Evercore ISI | Outperform → In-line |
| 2019-01-02 | Aggiornamento | Citigroup | Neutral → Buy |
| 2019-01-02 | Aggiornamento | Morgan Stanley | Underweight → Overweight |
| 2018-11-02 | Aggiornamento | Argus | Hold → Buy |
| 2018-10-16 | Iniziato | Barclays | Underweight |
| 2018-05-17 | Ripresa | Piper Jaffray | Overweight |
| 2018-02-06 | Reiterato | Citigroup | Neutral |
| 2018-01-03 | Iniziato | Evercore ISI | Outperform |
| 2018-01-03 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
Mostra tutto
Baxter International Inc Borsa (BAX) Ultime notizie
FDA issues alert for Baxter’s Novum infusion pumps - Crain's Chicago Business
FDA alerts of Baxter infusion pump issue - American Hospital Association
FDA warns on Baxter infusion pump issue that led to deaths - MassDevice
Baxter recalls certain Novum pumps over issues tied to 79 injuries, 2 deaths - MedTech Dive
What analysts say about Baxter International Inc. stockSuperior return velocity - Autocar Professional
Rep. Robert Bresnahan, Jr. Buys Baxter International Inc. (NYSE:BAX) Stock - MarketBeat
What drives Baxter International Inc. stock priceOutstanding yields - jammulinksnews.com
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter - Business Wire
Baxter International Inc. Stock Analysis and ForecastTremendous financial leverage - Autocar Professional
Mobile Lift Component Recalled due to Risk of Improper Attachment - fda.gov
Cullen Frost Bankers Inc. Raises Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Is Baxter International Inc. a good long term investmentLightning-fast growth - jammulinksnews.com
Richard Pzena's Strategic Acquisition of Baxter International Inc. Shares - GuruFocus
Cooke & Bieler LP Reduces Position in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Q2 2025 Financial Results Conference Call - AInvest
New York State Common Retirement Fund Has $21.34 Million Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
OVERSEA CHINESE BANKING Corp Ltd Invests $8.43 Million in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter: Margin-Focused Model Faces Growth Constraints (NYSE:BAX) - Seeking Alpha
How Renae Kezar will Lead Sustainability at Baxter - Healthcare Digital
Healthcare: Who is Renae Kezar, Baxter’s New CSO? - Sustainability Magazine
Further weakness as Baxter International (NYSE:BAX) drops 6.1% this week, taking five-year losses to 65% - simplywall.st
Baxter International Inc. (NYSE:BAX) to Issue Quarterly Dividend of $0.17 - MarketBeat
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors - Business Wire
Baxter International's Upcoming Q2 2025 Earnings AnnouncementNews and Statistics - IndexBox
What To Expect From Baxter International's Q2 2025 Earnings Report - Barchart.com
Baxter appoints Andrew Hider as CEO - MSN
Baxter Intl: Analyst Sentiments and 12-Month Price Targets - AInvest
Assessing Baxter Intl: Insights From 5 Financial Analysts - Benzinga
Baxter International (NYSE:BAX) Price Target Lowered to $27.00 at Morgan Stanley - MarketBeat
Morgan Stanley Trims Baxter International Price Target to $27 From $28, Maintains Underweight Rating - MarketScreener
Baxter price target lowered to $27 from $28 at Morgan Stanley - TipRanks
Baxter International's Dividend Policy: A Steady Beacon in a Shifting Medtech Landscape - AInvest
Baxter International Keeps Quarterly Dividend at $0.17 a Share, Payable Oct. 1 to Shareholders of Record Aug. 29 - MarketScreener
Baxter Declares Quarterly Dividend - Business Wire
Citigroup Cuts Baxter International (NYSE:BAX) Price Target to $32.00 - MarketBeat
Medical Equipment Maker Baxter International Names New CEO - MSN
TD Private Client Wealth LLC Buys 8,393 Shares of Baxter International Inc. (NYSE:BAX) - MarketBeat
UBS Affirms Neutral Rating on Baxter International (BAX) - MSN
Baxter International Inc. stock underperforms Friday when compared to competitors - MarketWatch
ARGA Investment Management LP Grows Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Evercore ISI Cuts Baxter International (NYSE:BAX) Price Target to $42.00 - MarketBeat
Analysts Set Baxter International Inc. (NYSE:BAX) PT at $36.14 - MarketBeat
Citigroup Adjusts Baxter International's Price Target to $32 From $34, Keeps Neutral Rating - MarketScreener
Baxter International (BAX) Receives a Hold from Wells Fargo - The Globe and Mail
Transformed Baxter, in search of stability after changes, turns to outsider CEO - Crain's Chicago Business
Bank of New York Mellon Corp Decreases Stock Holdings in Baxter International Inc. (NYSE:BAX) - MarketBeat
Baxter International Appoints Andrew Hider as New CEO - The Globe and Mail
Baxter International Inc Azioni (BAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):